These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22033152)

  • 1. Real-time image-based investigation of spheronization and drying phenomena using different pellet formulations.
    Burggraeve A; Sandler N; Heinämäki J; Räikkönen H; Remon JP; Vervaet C; De Beer T; Yliruusi J
    Eur J Pharm Sci; 2011 Dec; 44(5):635-42. PubMed ID: 22033152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of particle kinematics in spheronization via particle image velocimetry.
    Koester M; Thommes M
    Eur J Pharm Biopharm; 2013 Feb; 83(2):307-14. PubMed ID: 23000404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spheronization of solid lipid extrudates: Elucidation of spheroid formation mechanism.
    Petrovick GF; Breitkreutz J
    Eur J Pharm Biopharm; 2018 Apr; 125():148-158. PubMed ID: 29407224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evaluation of formulations for the preparation of pellets with high drug loading by extrusion/spheronization.
    Podczeck F; Knight P
    Pharm Dev Technol; 2006; 11(3):263-74. PubMed ID: 16895837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alginate-based pellets prepared by extrusion/spheronization: effect of the amount and type of sodium alginate and calcium salts.
    Sriamornsak P; Nunthanid J; Luangtana-anan M; Weerapol Y; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2008 May; 69(1):274-84. PubMed ID: 17962003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the drying technique on theophylline pellets prepared by extrusion-spheronization.
    Pérez J; Rabisková M
    Int J Pharm; 2002 Aug; 242(1-2):349-51. PubMed ID: 12176277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of microcrystalline cellulose and powder cellulose after extrusion/spheronization as studied by fourier transform Raman spectroscopy and environmental scanning electron microscopy.
    Fechner PM; Wartewig S; Füting M; Heilmann A; Neubert RH; Kleinebudde P
    AAPS PharmSci; 2003 Nov; 5(4):E31. PubMed ID: 15198519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrusion/spheronization--effect of moisture content and spheronization time on pellet characteristics.
    Iyer RM; Augsburger LL; Pope DG; Shah RD
    Pharm Dev Technol; 1996 Dec; 1(4):325-31. PubMed ID: 9552316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The preparation by extrusion/spheronization and the properties of pellets containing drugs, microcrystalline cellulose and glyceryl monostearate.
    Chatchawalsaisin J; Podczeck F; Newton JM
    Eur J Pharm Sci; 2005 Jan; 24(1):35-48. PubMed ID: 15626576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spheronization process particle kinematics determined by discrete element simulations and particle image velocimentry measurements.
    Koester M; García RE; Thommes M
    Int J Pharm; 2014 Dec; 477(1-2):81-7. PubMed ID: 25304094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and characterization of pellets using Avicel CL611 as spheronization aid.
    Puah SY; Yap HN; Chaw CS
    Drug Dev Ind Pharm; 2014 Mar; 40(3):418-24. PubMed ID: 23480532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pellet manufacturing by extrusion-spheronization using process analytical technology.
    Sandler N; Rantanen J; Heinämäki J; Römer M; Marvola M; Yliruusi J
    AAPS PharmSciTech; 2005 Sep; 6(2):E174-83. PubMed ID: 16353975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of chitosan-alginate as alternative pelletization aid to microcrystalline cellulose in extrusion/spheronization.
    Charoenthai N; Kleinebudde P; Puttipipatkhachorn S
    J Pharm Sci; 2007 Sep; 96(9):2469-84. PubMed ID: 17286294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of model drugs on the preparation of pellets by extrusion/spheronization: II. Spheronization parameters.
    Tomer G; Podczeck F; Newton JM
    Int J Pharm; 2002 Jan; 231(1):107-19. PubMed ID: 11719019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of papain containing pellets produced by extrusion-spheronization: an operational stage approach.
    Varca GH; Lopes PS; Ferraz HG
    Drug Dev Ind Pharm; 2015 Mar; 41(3):430-5. PubMed ID: 24410044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applicability of image analysis to support QbD driven development of pellets.
    Aničić N; Smrdel P; Kitak D; Morožin T; Jaklič M; Usenik P; Vidovič S
    Drug Dev Ind Pharm; 2021 Nov; 47(11):1794-1808. PubMed ID: 35389314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of microcrystalline cellulose grade on shape and shape distributions of pellets produced by extrusion-spheronization.
    Koo OM; Heng PW
    Chem Pharm Bull (Tokyo); 2001 Nov; 49(11):1383-7. PubMed ID: 11724226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spheronization of solid lipid extrudates: A novel approach on controlling critical process parameters.
    Petrovick GF; Pein M; Thommes M; Breitkreutz J
    Eur J Pharm Biopharm; 2015 May; 92():15-21. PubMed ID: 25681745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gellan gum and polyvinylpyrrolidone (PVP) as binding agents in extrusion/spheronization pellet formulations.
    Barbosa EJ; Ferraz HG
    Acta Pharm; 2019 Mar; 69(1):99-109. PubMed ID: 31259713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.